Related Experiment Videos
[Alpha-fetoprotein in umbilical cord blood and hyperbilirubinemia in normal neonates]
R Hodr1, A Stroufová, M Kepertová
1Ustav pro péci o matku a dítĕ, Praha.
Insights
Higher alpha-fetoprotein (AFP) levels in umbilical cord blood indicate increased risk for neonatal hyperbilirubinemia. AFP is a useful liver maturity indicator but doesn't guarantee prediction in all infants.
Area of Science:
- Neonatal Medicine
- Biochemistry
- Pediatrics
Context:
- Neonatal hyperbilirubinemia is a common condition requiring monitoring.
- Alpha-fetoprotein (AFP) is a protein produced by the fetal liver.
- Assessing liver function in newborns is crucial for early intervention.
Purpose:
- To investigate the correlation between umbilical cord blood alpha-fetoprotein (AFP) levels and the development of neonatal hyperbilirubinemia.
- To evaluate AFP as a predictive marker for hyperbilirubinemia and the need for phototherapy in newborns.
Summary:
- A study of 154 neonates found significantly higher mean AFP values in infants with hyperbilirubinemia ( > 205 µmol/l) compared to controls.
- Elevated AFP levels (> 100 mg/l) in umbilical cord blood were associated with a higher probability of developing hyperbilirubinemia and increased need for phototherapy.
- AFP concentration above 130 mg/l suggested certainty of hyperbilirubinemia development; however, AFP is a useful indicator of liver maturity, not a definitive predictor for individual neonates.
Impact:
- Identifies elevated umbilical cord AFP as a significant risk factor for neonatal hyperbilirubinemia.
- Suggests careful observation for neonates with cord AFP levels above 100 mg/l.
- Highlights AFP's role in assessing neonatal liver function and potential hyperbilirubinemia risk.
Abstract:
In a group of 154 mature normal neonates the authors recorded significantly higher mean alpha-fetoprotein values in children with hyperbilirubinaemia (higher than 205 mumol/l) than in other neonates. The differences were observed also in children of equal gestation age. Development of hyperbilirubinaemia is more probable and indication for phototherapy is significantly higher in neonates with alpha-fetoprotein levels in umbilical blood above 100 mg/l and these infants must be carefully observed. When the concentration is above 130 mg/l, the development of hyperbilirubinaemia may be assumed with certainty. Examination of alpha-fetoprotein in umbilical blood is an useful indicator of the functional maturity of the liver, but does not ensure reliable prediction of hyperbilirubinaemia in individual neonates. A concentration of alpha-fetoprotein above 100 mg/l is exceptional among neonates without hyperbilirubinaemia, while lower values do not rule out the development of hyperbilirubinaemia.